Decentralized AI in drug R&D could democratize discovery, reduce costs, and challenge traditional pharma, but validation hurdles remain.
The post Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs appeared first on Crypto Briefing.
Decentralized AI in drug R&D could democratize discovery, reduce costs, and challenge traditional pharma, but validation hurdles remain.
The post Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs appeared first on Crypto Briefing.